158 related articles for article (PubMed ID: 37494667)
1. Th1 promotes M1 polarization of intestinal macrophages to regulate colitis-related mucosal barrier damage.
Ruan S; Xu L; Sheng Y; Wang J; Zhou X; Zhang C; Guo L; Li W; Han C
Aging (Albany NY); 2023 Apr; 15(14):6721-6735. PubMed ID: 37494667
[TBL] [Abstract][Full Text] [Related]
2. NOX4 promotes mucosal barrier injury in inflammatory bowel disease by mediating macrophages M1 polarization through ROS.
Han C; Sheng Y; Wang J; Zhou X; Li W; Zhang C; Guo L; Yang Y
Int Immunopharmacol; 2022 Mar; 104():108361. PubMed ID: 34949550
[TBL] [Abstract][Full Text] [Related]
3. PCSK6 mediates Th1 differentiation and promotes chronic colitis progression and mucosal barrier injury via STAT1.
Mei X; Zhou H; Song Z; Yang X; Liu X; Fei J; Shen Y; Wang X
Aging (Albany NY); 2023 May; 15(10):4363-4373. PubMed ID: 37211384
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PSCK6-AS1-HIPK2 promotes Th1 differentiation via STAT1 phosphorylation to regulate colitis-related mucosal barrier damage.
Han C; Sheng Y; Wang J; Zhou X; Li W; Zhang C; Wu S; Yang Y; Ruan S
Int Immunopharmacol; 2023 Apr; 117():109992. PubMed ID: 37012876
[TBL] [Abstract][Full Text] [Related]
5. Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way.
Wu Y; Wu B; Zhang Z; Lu H; Fan C; Qi Q; Gao Y; Li H; Feng C; Zuo J; Tang W
FASEB J; 2020 Jun; 34(6):8028-8043. PubMed ID: 32301543
[TBL] [Abstract][Full Text] [Related]
6. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
[TBL] [Abstract][Full Text] [Related]
7. Moronic acid improves intestinal inflammation in mice with chronic colitis by inhibiting intestinal macrophage polarization.
Ruan S; Zha L
J Biochem Mol Toxicol; 2022 Nov; 36(11):e23188. PubMed ID: 35924425
[TBL] [Abstract][Full Text] [Related]
8. M1 intestinal macrophages-derived exosomes promote colitis progression and mucosal barrier injury.
Du R; Chen S; Han C; He Z; Pei H; Yang Y
Aging (Albany NY); 2024 Mar; 16(6):5703-5710. PubMed ID: 38535999
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9a-5p-NOX4 inhibits intestinal inflammatory injury by regulating the M1 polarization of intestinal macrophages.
Li W; Sheng Y; Wang J; Wu S; Han C
J Biochem Mol Toxicol; 2023 Feb; 37(2):e23245. PubMed ID: 36281492
[TBL] [Abstract][Full Text] [Related]
10.
Liu L; Liang L; Liang H; Wang M; Lu B; Xue M; Deng J; Chen Y
Front Immunol; 2019; 10():1324. PubMed ID: 31249571
[TBL] [Abstract][Full Text] [Related]
11. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
12. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
13. Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis.
Abron JD; Singh NP; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
PLoS One; 2018; 13(7):e0199631. PubMed ID: 30024891
[TBL] [Abstract][Full Text] [Related]
14. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
[TBL] [Abstract][Full Text] [Related]
15. Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease.
Martin-Rodriguez O; Gauthier T; Bonnefoy F; Couturier M; Daoui A; Chagué C; Valmary-Degano S; Gay C; Saas P; Perruche S
Front Immunol; 2021; 12():754475. PubMed ID: 35003066
[TBL] [Abstract][Full Text] [Related]
16. S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization.
Wang X; Chen S; Xiang H; Wang X; Xiao J; Zhao S; Shu Z; Ouyang J; Liang Z; Deng M; Chen X; Zhang J; Liu H; Quan Q; Gao P; Fan J; Chen AF; Lu H
Biochem Pharmacol; 2022 Jul; 201():115077. PubMed ID: 35537530
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5.
Lu J; Liu D; Tan Y; Li R; Wang X; Deng F
Dig Dis Sci; 2021 Nov; 66(11):3803-3812. PubMed ID: 34085173
[TBL] [Abstract][Full Text] [Related]
18. Tollip Orchestrates Macrophage Polarization to Alleviate Intestinal Mucosal Inflammation.
Liu X; Ren X; Zhou L; Liu K; Deng L; Qing Q; Li J; Zhi F; Li M
J Crohns Colitis; 2022 Aug; 16(7):1151-1167. PubMed ID: 35134154
[TBL] [Abstract][Full Text] [Related]
19. Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway.
Huang C; Wang J; Liu H; Huang R; Yan X; Song M; Tan G; Zhi F
BMC Med; 2022 Apr; 20(1):148. PubMed ID: 35422042
[TBL] [Abstract][Full Text] [Related]
20. A Molecular Targeted Immunotherapeutic Strategy for Ulcerative Colitis via Dual-targeting Nanoparticles Delivering miR-146b to Intestinal Macrophages.
Deng F; He S; Cui S; Shi Y; Tan Y; Li Z; Huang C; Liu D; Zhi F; Peng L
J Crohns Colitis; 2019 Mar; 13(4):482-494. PubMed ID: 30445446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
